Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients.
Lin D, Yang HI, Nguyen N, Hoang J, Kim Y, Vu V, Le A, Chaung K, Nguyen V, Trinh H, Li J, Zhang J, Hsing A, Chen CJ, Nguyen MH.
Lin D, et al.
Aliment Pharmacol Ther. 2016 Oct;44(8):846-55. doi: 10.1111/apt.13774. Epub 2016 Aug 23.
Aliment Pharmacol Ther. 2016.
PMID: 27549411